
Eric Olson
Examiner (ID: 316, Phone: (571)272-9051 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1693, 1673, 1623 |
| Total Applications | 1758 |
| Issued Applications | 971 |
| Pending Applications | 175 |
| Abandoned Applications | 632 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7316924
[patent_doc_number] => 20040224058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Maltitol solutions with high maltitol content and methods of making same'
[patent_app_type] => new
[patent_app_number] => 10/804502
[patent_app_country] => US
[patent_app_date] => 2004-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4978
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20040224058.pdf
[firstpage_image] =>[orig_patent_app_number] => 10804502
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/804502 | Maltitol solutions with high maltitol content and methods of making same | Mar 18, 2004 | Abandoned |
Array
(
[id] => 5142695
[patent_doc_number] => 20070004911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-04
[patent_title] => 'Silylated oligonucleotide compounds'
[patent_app_type] => utility
[patent_app_number] => 10/550217
[patent_app_country] => US
[patent_app_date] => 2004-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6426
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20070004911.pdf
[firstpage_image] =>[orig_patent_app_number] => 10550217
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/550217 | Silylated oligonucleotide compounds | Mar 18, 2004 | Abandoned |
Array
(
[id] => 42800
[patent_doc_number] => 07781408
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-24
[patent_title] => 'Formulations for mediating inflammation and for reducing blood cholesterol'
[patent_app_type] => utility
[patent_app_number] => 10/551789
[patent_app_country] => US
[patent_app_date] => 2004-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 18
[patent_no_of_words] => 23378
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/781/07781408.pdf
[firstpage_image] =>[orig_patent_app_number] => 10551789
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/551789 | Formulations for mediating inflammation and for reducing blood cholesterol | Mar 11, 2004 | Issued |
Array
(
[id] => 7672927
[patent_doc_number] => 20040180852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-16
[patent_title] => 'Use of multivalent glycodendrimers to inhibit the activity of human immunodeficiency virus'
[patent_app_type] => new
[patent_app_number] => 10/796707
[patent_app_country] => US
[patent_app_date] => 2004-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13812
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20040180852.pdf
[firstpage_image] =>[orig_patent_app_number] => 10796707
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/796707 | Use of multivalent glycodendrimers to inhibit the activity of human immunodeficiency virus | Mar 8, 2004 | Abandoned |
Array
(
[id] => 7319345
[patent_doc_number] => 20040225015
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Carba-sugar amine derivative and glycolipid metabolic disorder treating agent containing the same as active ingredient'
[patent_app_type] => new
[patent_app_number] => 10/793857
[patent_app_country] => US
[patent_app_date] => 2004-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 11831
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0225/20040225015.pdf
[firstpage_image] =>[orig_patent_app_number] => 10793857
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/793857 | Carba-sugar amine derivative and glycolipid metabolic disorder treating agent containing the same as active ingredient | Mar 7, 2004 | Issued |
Array
(
[id] => 7977651
[patent_doc_number] => 08071572
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-12-06
[patent_title] => 'Preventive/remedy for obesity'
[patent_app_type] => utility
[patent_app_number] => 10/547776
[patent_app_country] => US
[patent_app_date] => 2004-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3871
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/071/08071572.pdf
[firstpage_image] =>[orig_patent_app_number] => 10547776
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/547776 | Preventive/remedy for obesity | Mar 7, 2004 | Issued |
Array
(
[id] => 7447244
[patent_doc_number] => 20040186081
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-23
[patent_title] => 'Naaladase inhibitors for treating opioid tolerance'
[patent_app_type] => new
[patent_app_number] => 10/791296
[patent_app_country] => US
[patent_app_date] => 2004-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 22348
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20040186081.pdf
[firstpage_image] =>[orig_patent_app_number] => 10791296
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/791296 | Naaladase inhibitors for treating opioid tolerance | Mar 2, 2004 | Abandoned |
Array
(
[id] => 7426664
[patent_doc_number] => 20040229824
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-18
[patent_title] => 'Methods for using specific saccharides for treating Alzheimer\'s disease and other amyloidoses'
[patent_app_type] => new
[patent_app_number] => 10/793175
[patent_app_country] => US
[patent_app_date] => 2004-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11197
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20040229824.pdf
[firstpage_image] =>[orig_patent_app_number] => 10793175
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/793175 | Methods for using glucose pentasulfate for treating amyloid associated with type II diabetes | Mar 2, 2004 | Issued |
Array
(
[id] => 7326832
[patent_doc_number] => 20040253219
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-16
[patent_title] => 'Non-toxic crosslinking reagents to resist curve progression in scoliosis and increase disc permeability'
[patent_app_type] => new
[patent_app_number] => 10/786861
[patent_app_country] => US
[patent_app_date] => 2004-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10292
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 28
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0253/20040253219.pdf
[firstpage_image] =>[orig_patent_app_number] => 10786861
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/786861 | Non-toxic crosslinking reagents to resist curve progression in scoliosis and increase disc permeability | Feb 23, 2004 | Issued |
Array
(
[id] => 7325446
[patent_doc_number] => 20040138239
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-15
[patent_title] => 'Compositions and methods for targeting cerebral circulation and treatment of headache'
[patent_app_type] => new
[patent_app_number] => 10/480162
[patent_app_country] => US
[patent_app_date] => 2004-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6738
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0138/20040138239.pdf
[firstpage_image] =>[orig_patent_app_number] => 10480162
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/480162 | Compositions and methods for targeting cerebral circulation and treatment of headache | Feb 22, 2004 | Abandoned |
Array
(
[id] => 359840
[patent_doc_number] => 07485719
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-02-03
[patent_title] => 'Crosslinkable polysaccharide derivative, process for producing the same, crosslinkable polysaccharide composition, and medical treatment material'
[patent_app_type] => utility
[patent_app_number] => 10/546256
[patent_app_country] => US
[patent_app_date] => 2004-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18684
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/485/07485719.pdf
[firstpage_image] =>[orig_patent_app_number] => 10546256
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/546256 | Crosslinkable polysaccharide derivative, process for producing the same, crosslinkable polysaccharide composition, and medical treatment material | Feb 19, 2004 | Issued |
Array
(
[id] => 5597081
[patent_doc_number] => 20060160999
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-20
[patent_title] => 'Reagents and methods for preparing lps antagonist b1287 and stereoisomers thereof'
[patent_app_type] => utility
[patent_app_number] => 10/546132
[patent_app_country] => US
[patent_app_date] => 2004-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25664
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20060160999.pdf
[firstpage_image] =>[orig_patent_app_number] => 10546132
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/546132 | Reagents and methods for preparing LPS antagonist B1287 and stereoisomers thereof | Feb 17, 2004 | Issued |
Array
(
[id] => 7426554
[patent_doc_number] => 20040229817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-18
[patent_title] => 'Inhibitors of Hepatitis C virus, compositions and treatments using the same'
[patent_app_type] => new
[patent_app_number] => 10/782679
[patent_app_country] => US
[patent_app_date] => 2004-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14406
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20040229817.pdf
[firstpage_image] =>[orig_patent_app_number] => 10782679
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/782679 | Inhibitors of Hepatitis C virus, compositions and treatments using the same | Feb 17, 2004 | Abandoned |
Array
(
[id] => 7409449
[patent_doc_number] => 20040176273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-09
[patent_title] => 'Regulation of mammalian keratinous tissue using hexamidine compositions'
[patent_app_type] => new
[patent_app_number] => 10/780267
[patent_app_country] => US
[patent_app_date] => 2004-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18203
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20040176273.pdf
[firstpage_image] =>[orig_patent_app_number] => 10780267
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/780267 | Regulation of mammalian keratinous tissue using hexamidine compositions | Feb 16, 2004 | Abandoned |
Array
(
[id] => 7353621
[patent_doc_number] => 20040249178
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-09
[patent_title] => 'Conjugates and compositions for cellular delivery'
[patent_app_type] => new
[patent_app_number] => 10/780447
[patent_app_country] => US
[patent_app_date] => 2004-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 51
[patent_no_of_words] => 53151
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20040249178.pdf
[firstpage_image] =>[orig_patent_app_number] => 10780447
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/780447 | Conjugates and compositions for cellular delivery | Feb 12, 2004 | Issued |
Array
(
[id] => 7139006
[patent_doc_number] => 20050182241
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-18
[patent_title] => 'Universal support for nucleic acid synthesis'
[patent_app_type] => utility
[patent_app_number] => 10/776695
[patent_app_country] => US
[patent_app_date] => 2004-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2122
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20050182241.pdf
[firstpage_image] =>[orig_patent_app_number] => 10776695
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/776695 | Universal support for nucleic acid synthesis | Feb 11, 2004 | Abandoned |
Array
(
[id] => 7276336
[patent_doc_number] => 20040235787
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Compositions comprising sugar beet pectin and carotenoids'
[patent_app_type] => new
[patent_app_number] => 10/486705
[patent_app_country] => US
[patent_app_date] => 2004-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2517
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20040235787.pdf
[firstpage_image] =>[orig_patent_app_number] => 10486705
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/486705 | Compositions comprising sugar beet pectin and carotenoids | Feb 11, 2004 | Abandoned |
Array
(
[id] => 7122024
[patent_doc_number] => 20050013853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-20
[patent_title] => 'Anti-proliferative drugs'
[patent_app_type] => utility
[patent_app_number] => 10/774694
[patent_app_country] => US
[patent_app_date] => 2004-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 8580
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0013/20050013853.pdf
[firstpage_image] =>[orig_patent_app_number] => 10774694
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/774694 | Anti-proliferative drugs | Feb 9, 2004 | Abandoned |
Array
(
[id] => 7379036
[patent_doc_number] => 20040220267
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-04
[patent_title] => 'Derivatives of pentacyclic nortriterpene quinone methides as compounds useful in the treatment of inflammatory, neurodegenerative, and neoplastic diseases'
[patent_app_type] => new
[patent_app_number] => 10/773903
[patent_app_country] => US
[patent_app_date] => 2004-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1696
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20040220267.pdf
[firstpage_image] =>[orig_patent_app_number] => 10773903
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/773903 | Derivatives of pentacyclic nortriterpene quinone methides as compounds useful in the treatment of inflammatory, neurodegenerative, and neoplastic diseases | Feb 5, 2004 | Abandoned |
Array
(
[id] => 5721285
[patent_doc_number] => 20060074061
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-06
[patent_title] => 'Formulations of glucocorticoids to treat pathologic ocular angiogenesis'
[patent_app_type] => utility
[patent_app_number] => 10/545053
[patent_app_country] => US
[patent_app_date] => 2004-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3178
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20060074061.pdf
[firstpage_image] =>[orig_patent_app_number] => 10545053
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/545053 | Formulations of glucocorticoids to treat pathologic ocular angiogenesis | Feb 4, 2004 | Abandoned |